Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

286 trials

2025-522834-30-01
Recruiting
Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases
Phase 2 · Netherlands · 1 site
Registry update: 29 Jun 2026
NCT07767370
Recruiting
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
Early phase 1 · China · 1 site
Registry update: 17 Aug 2026
NCT07456566
Recruiting
Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
Not applicable · United States · 1 site
Registry update: 23 Jul 2026
NCT07913347
Recruiting
Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
Phase 1/2 · Japan, United States · 12 sites
Registry update: 3 Nov 2026
NCT07691138
Recruiting
Stopping PPI Therapy in Inactive IBD
Phase 4 · United Kingdom · 1 site
Registry update: 8 Jul 2026
NCT07665723
Recruiting
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Phase 1 · Belgium, Germany, United Kingdom, Poland, United States · 18 sites
Registry update: 16 Oct 2026
2025-524404-29-00
Recruiting
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Phase 2 · Czechia, France, Greece, Croatia, Hungary, Italy, Lithuania, Latvia, Poland, Portugal, Slovakia · 61 sites
Registry update: 21 Oct 2026
NCT07341282
Recruiting
Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
Phase 2 · Canada · 1 site
Registry update: 9 Oct 2026
NCT07692165
Recruiting
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
Phase 1/2 · China · 15 sites
Registry update: 9 Jul 2026
NCT07606339
Recruiting
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
Not applicable · Austria · 1 site
Registry update: 3 Nov 2026
NCT06228352
Recruiting
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
Not applicable · France · 1 site
Registry update: 24 Jun 2026
2025-522362-78-00
Recruiting
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
Phase 4 · Germany, Denmark, Spain, Italy, Poland · 10 sites
Registry update: 30 Oct 2026
NCT07470879
Recruiting
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · Australia, Canada, Germany, Finland, France, United Kingdom, Israel, Italy, Japan, Poland, Slovakia, United States · 53 sites
Registry update: 26 Oct 2026
2025-522001-38-00
Recruiting
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase 2 · Belgium, Bulgaria, Czechia, Germany, Croatia, Italy, Poland, Slovakia · 40 sites
Registry update: 20 Jul 2026
NCT07577856
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hungary, Israel, India, Italy, Japan, South Korea, Mexico, Malaysia, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Taiwan, United States · 327 sites
Registry update: 3 Nov 2026
NCT07541261
Recruiting
A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
Not applicable · Saudi Arabia · 1 site
Registry update: 2 Jul 2026
NCT07483073
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Phase 2 · Belgium, Brazil, Canada, China, Germany, Hungary, Israel, Italy, Poland, United States · 71 sites
Registry update: 4 Nov 2026
NCT07621783
Recruiting
Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context
Not applicable · Belgium · 1 site
Registry update: 2 Jun 2026
NCT07591012
Recruiting
Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease
Not applicable · Italy · 1 site
Registry update: 15 May 2026
NCT07513181
Recruiting
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Phase 2 · Poland, United States · 16 sites
Registry update: 21 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.